Näytetään tulokset 1 - 10 / 7271
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Systemic Aggregatibacter actinomycetemcomitans Leukotoxin-Neutralizing Antibodies in Periodontitis

Vertaisarvioitu
DOI
10.1902/jop.2016.160193
Johansson, Anders; Buhlin, Kare; Sorsa, Timo; Pussinen, Pirkko J.
Journal of periodontology2017

"Interferon β-1b–neutralizing antibodies 5 years after clinically isolated syndrome"

Vertaisarvioitu
DOI
10.1212/WNL.0b013e31822c90d7
Hartung H-P; Freedman M; Polman C; Edan G; Kappos L; Miller D; Montalbán X; Barkhof F; Petkau J; Whi...
NEUROLOGY2011

Interferon beeta-1b-neutralizing antibodies 5 years after clinically isolated syndrome

Vertaisarvioitu
Hartung HP; Freedman MS; Polman CH; Edan G; Kappos L; Miller DH; Montalban X; Barkhof F; Perkau J; W...
NEUROLOGY2011

HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies

Vertaisarvioitu
DOI
10.1016/j.vaccine.2017.11.075
Serwanga, Jennifer; Ssemwanga, Deogratius; Muganga, Michael; Nakiboneka, Ritah; Nakubulwa, Susan; Ki...
Vaccine2018

Characterization of Infecting Strains and Superantigen-Neutralizing Antibodies in Staphylococcus aureus Bacteremia

Vertaisarvioitu
Grumann, Dorothee; Ruotsalainen, Eeva; Kolata, Julia; Kuusela, Pentti; Järvinen, Asko; Kontinen, Ves...
Clinical and vaccine immunology2011

Determination of serum neutralizing antibodies reveals important difference in quality of antibodies against pertussis toxin in children after infection

Vertaisarvioitu
DOI
10.1016/j.vaccine.2021.02.045
Zhang Yuxiao, Li Yarong, Chen Zhiyun, Liu Xiaoguai, Peng Xiaokang, He Qiushui
Vaccine2021

Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/eji.202149535
Haveri, Anu;Ekström, Nina;Solastie, Anna;Virta, Camilla;Österlund, Pamela;Isosaari, Elina;Nohynek, H...
EUROPEAN JOURNAL OF IMMUNOLOGY2021

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

Vertaisarvioitu
Raki, Mari; Särkioja, Merja Annikki; Escutenaire, Sophie; Kangasniemi, Lotta; Haavisto, Elina; Kaner...
Journal of gene medicine2011

Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection

Vertaisarvioitu
Reinholm A; Maljanen S; Jalkanen P; Altan E; Tauriainen S; Belik M; Skön M; Haveri A; Österlund P; I...
Communications Medicine2024

Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s43856-024-00457-3
Reinholm, Arttu; Maljanen, Sari; Jalkanen, Pinja; Altan, Eda; Tauriainen, Sisko; Belik, Milja; Skön,...
Communications medicine2024

Systemic Aggregatibacter actinomycetemcomitans Leukotoxin-Neutralizing Antibodies in Periodontitis

Vertaisarvioitu
DOI
10.1902/jop.2016.160193
2017

"Interferon β-1b–neutralizing antibodies 5 years after clinically isolated syndrome"

Vertaisarvioitu
DOI
10.1212/WNL.0b013e31822c90d7
2011

Interferon beeta-1b-neutralizing antibodies 5 years after clinically isolated syndrome

Vertaisarvioitu
2011

HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies

Vertaisarvioitu
DOI
10.1016/j.vaccine.2017.11.075
2018

Characterization of Infecting Strains and Superantigen-Neutralizing Antibodies in Staphylococcus aureus Bacteremia

Vertaisarvioitu
2011

Determination of serum neutralizing antibodies reveals important difference in quality of antibodies against pertussis toxin in children after infection

Vertaisarvioitu
DOI
10.1016/j.vaccine.2021.02.045
2021

Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/eji.202149535
2021

Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients

Vertaisarvioitu
2011

Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection

Vertaisarvioitu
2024

Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s43856-024-00457-3
2024